Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, announced Wednesday that it plans to invest $27 ...
Even as President Donald Trump wages a very public fight against diversity, equity and inclusion (DEI) initiatives in the ...
The pharma group has just announced that it will build four new manufacturing facilities in the US – at a cost of around $27 ...
After announcing plans to build four manufacturing sites in the U.S. on Wednesday, Eli Lilly CEO Dave Ricks skillfully ...
While announcing billions of dollars in new U.S. investments, company chief David Ricks called for an extension of 2017 tax ...
Eli Lilly (NYSE:LLY) shares soar, driven by strong growth in weight-loss drugs, major investments, and bullish analyst ratings.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback